Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change to the notice of Fiskars Corporation’s Annual General Meeting

Fiskars CorporationStock Exchange ReleaseFebruary 25, 2022 at 12:00 EET Change to the notice of Fiskars Corporation’s Annual General MeetingThe venue of Fiskars Corporation’s Annual General Meeting 2022 will change and accordingly the notice to the Annual General Meeting is changed so that the meeting is held at Itämerentori 2, Helsinki. In other respects, the notice to the Annual General Meeting published on February 4, 2022 is unchanged. The notice to the Annual General Meeting is available on the company’s website at https://fiskarsgroup.com/investors/corporate-governance/annual-

Gamifant (emapalumab) recommended for approval in China for treatment of primary haemophagocytic lymphohistiocytosis (HLH)

Sobi® today announces that the Center for Drug Evaluation (CDE) has recommended approval of Gamifant® to the National Medical Products Administration of China (NMPA). The indication is for treatment of adult and paediatric (newborn and older) patients with primary haemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance to conventional HLH therapy. Primary HLH is an ultra-rare, life-threatening, hyperinflammatory disorder, characterised by uncontrolled activation of the immune system. Morbidity and mortality are high due to lack of

Toivo Group Plc starts implementing an apartment building project of 69 apartments in Järvenpää

Press release, 25 February 2022 12:00 Toivo Group Plc (“Company” or “Toivo”) has started the implementation of an apartment building project comprising two buildings in Lepola, Järvenpää. The Company estimates the total value of the project to be approximately EUR 11 million. The project will be executed according to class-A energy standards, and the apartments will be heated by environmentally friendly geothermal energy. The site is expected to attract households of different sizes who appreciate the proximity to the train station and design solutions that improve the comfort of

Ikano Bank AB (publ) Year-End Report 2021

“We are on our way to becoming a fully digitalised, sustainable bank. During 2021 we successfully launched the first two products on our new digital platform. Ingka Group became part-owner of the Bank during the year creating huge possibilities. We accelerated the transformation further in order to have a renewed bank within a few years where we have shut down legacy systems. We have a long-term strategy underpinning everything we do. We offer simple and fair financial solutions based on the latest technology thereby giving better access to finance to more of the many people.” Henrik

Combined Zaplox & Agilysys Solution Enables Hotels To Greet Post-Pandemic Travel Surge With Ease

Hospitality Tech Firms’ Joint Solution - Agilysys rGuest Express With Zaplox Mobile Keys – Help Ease Labor Shortages And Meet Demand For Contactless Solutions And Has been Chosen By Over 40 Hotels, Resorts And Casinos In North AmericaALPHARETTA, GA, USA / LUND, SWEDEN. February 25, 2022 - Zaplox  ("ZAPLOX"), the market innovator of the contact-free mobile guest journey and mobile key services for hotels, resorts and casinos, and Agilysys, Inc.  (Nasdaq: AGYS), a leading global provider of next-generation cloud-native SaaS and on-premise

Communique from extraordinary general meeting in NeoDynamics AB (publ)

The extraordinary general meeting in NeoDynamics AB (publ) (the “Company”) was held on 25 February 2022 at the Company’s premises at Lejonvägen 14, Lidingö whereby the shareholders primarily resolved on the following matters.   The general meeting resolved in accordance with the Board of Director’s proposal on a new issue of shares with preferential rights for existing shareholders. The resolution increases the Company’s share capital with no more than SEK 6,025,059.20 by an issue of no more than 60,250,592 shares. The right to subscribe for shares shall, with preferential rights for

Relais will publish its Financial Statements Bulletin 2021 on March 3, 2022 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release 25 February 2022 at 11:00 a.m. EET  Relais Group Plc will publish its Financial Statements Bulletin 2021 on Thursday, March 3, 2022 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on March 3, 2022, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Pekka Raatikainen will host the event. The webcast can be followed at https://relais.videosync.fi/interimreport-q4-2021.

Notice to attend the Annual General Meeting

The shareholders of SSAB AB (publ) (company registration number 556016-3429) are hereby given notice to attend the Annual General Meeting to be held on Wednesday, April 6, 2022. Due to the corona virus, the Board of Directors has decided that the Annual General Meeting will be held without the physical presence of shareholders, representatives or third parties, and that the shareholders will only be able to exercise their voting rights in advance through so-called postal voting ahead of the meeting.The Government of Sweden has started to phase out infection control measures but has, due to

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 51 - 25 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Year End Report 2021

October 1 - December 31, 2021 · Net sales SEK 45,462 · Operation profit SEK -5,503,595 · Profit after financial items SEK -5,490,108 · Earnings per share SEK -0,21 January 1 - December 31, 2021 · Net sales SEK 263,040 · Operation profit SEK -14,907,945 · Profit after financial items SEK -14,841,085 · Earnings per share SEK -0,58 · Cash and cash equivalents 2021-12-31 SEK 8,782,891   Number of shares Per 2021-12-31, 25 558 597 shares   Proposed dividend The Board proposes that no dividend be paid for the 2021 financial year.   Upcoming

BioStock: Project manager sees great potential in Lipum’s candidate

Umeå-based Lipum is in late preclinical development phase with the candidate drug SOL-116 with the ambition to treat chronic inflammatory diseases. The development work is led by Dr Maria Wanderoy, who recently took up the role as Project Director at Lipum. BioStock contacted Wanderoy to hear her thoughts on the SOL-116 project, her first months working at the company and the development plans for the candidate.Read the full article at biostock.se: https://www.biostock.se/en/2022/02/project-manager-sees-great-potential-in-lipums-candidate/ This is a press release from BioStock -

Picadeli turns up the volume on new sustainability efforts – will eliminate 120 tons of plastic annually

After dropping all red meat this fall, food tech pioneer Picadeli puts focus on reducing the plastic with a plastic-free bowl lid and eliminates single-use plastic dressing cups. All measures are part of a long-term sustainability engagement to reduce the company's climate footprint. The initiative aims to set an example for the food industry to act on the accelerating climate crisis and the plastic issue. According to data from Earth Day, 8 million metric tons of plastic are thrown into the ocean annually, proving to be dangerous to our planet, health and wildlife. Single-use plastics

Scandinavian ChemoTech's TSE technology shows great initial pre-trial results in India

TSE treatment was performed on eight advanced stage cancer patients who did not respond to conventional treatments. The evaluation showed the desirable goal of tumour shrinkage.As earlier reported the trials are performed at the large Indian governmentally run hospital chain AIIMS - All India Institute of Medical Sciences. The trial program is part of the India-Sweden Healthcare Innovation Centre, which in turn is a part of a Swedish Indian government healthcare collaboration. ChemoTech signed an agreement with AIIMS Jodhpur and India-Sweden Healthcare Innovation Centre on 11 November

Getinge introduces a flexible workplace deal for employees in the UK and Ireland

Following extensive consultation with employees, Getinge has announced and successfully implemented a long-term flexible workplace deal in the UK and Irish organisations. All eligible employees who traditionally would have been office based, have accepted an offer to work at least 3 days per week from home allowing greater flexibility for post pandemic working.The announcement reflects the company’s commitment to supporting its people and responding to changing working patterns accelerated by Covid. Since the outbreak of COVID-19, following government guidelines, and ensuring employees

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Flagging notification, 25 February 2022 at 10.30 am EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed below the 5% disclosure limit on total holding in shares and voting rights on 23 February 2022. Total position of BlackRock, Inc. and its funds subject to the notification: % of % of shares Total of Total number of shares shares and voting both in % and voting

Appointments Committee's proposal for the composition of Raute Corporation's Board of Directors

RAUTE CORPORATION STOCK EXCHANGE RELEASE 25 FEBRUARY 2022 at 10:10 a.m.    APPOINTMENTS COMMITTEE’S PROPOSAL FOR THE COMPOSITION OF RAUTE CORPORATION’S BOARD OF DIRECTORS   Raute Corporation’s Appointments Committee has announced that it will propose to the Annual General Meeting, which will convene on March 31, 2022, that the number of Board members be increased from the current six members to seven members. The Appointments Committee has considered that the company’s international growth and business development goals can be better supported by reinforcing the Board.

Hexagon Agility receives order from RenewGas Transportation for Mobile Pipeline® modules to deliver renewable natural gas

Hexagon Agility has received an order for Mobile Pipeline[®] TITAN[®] modules from RenewGas Transportation, a leading provider of complete turnkey transportation solutions for renewable natural gas (RNG). These modules will be used to transport and deliver RNG derived from agricultural waste.   The order represents an estimated value of USD 5.5 million (approx. NOK 49.5 million) for delivery in Q4 2022 thru Q1 2023. “We’ve built our mobile pipeline fleet around Hexagon Agility’s TITAN modules, which are essential to our growth in the RNG market, the cleanest solution available to

BioStock: Pila Pharma’s CEO on building the company since its IPO

“We’re on our way.” This is how Pila Pharma CEO Dorte X. Gram starts the 2021 year end report that was released last week. During the first half of the year as a public company, the focus has been on building the high-quality team that will drive the development of the drug candidate XEN-D0501, hopefully all the way to market. In connection with the newly released report, BioStock has contacted Gram to get her view of the past year.Read the full article at biostock.se:https://www.biostock.se/en/2022/02/pila-pharmas-ceo-on-building-the-company-since-its-ipo/This is a press release from

Success for Axfood’s sustainability efforts in 2021

In conjunction with the publication of Axfood’s Annual and Sustainability Report for 2021, the following summary of improvements in the Group’s sustainability efforts is presented. Examples of the important progress made during the year include a continued reduction of food waste, lower emissions from own operations and the fact that all of the Group’s 262 trucks can now be powered by fossil-free fuel.“There are no shortcuts when it comes to successful sustainability work. While the challenges are growing in number, it is important to address all of the areas impacted by the Group’s

Heliospectra carries out share issues by way of set-off totalling approximately SEK 13.1 million

(Gothenburg, Sweden February 25, 2022, at 09:00 CET) The board of directors of Heliospectra AB (publ) (the “Company” or “Heliospectra”) has today, pursuant to the authorization granted by the Annual General Meeting on 20 May 2021, resolved upon directed issues of shares totalling approximately SEK 13.1 million (the “Directed Issues”), to three of the Company’s main shareholders, i.e., Weland Stål AB, ADMA Förvaltnings AB, and Corespring New Technology AB (the “Main Owner(s)”). The subscription price amounts to approximately SEK 1.53 per share. The issue funds have been paid by set-off of

Discussion event for shareholders on YIT’s events and financial statements in 2021

YIT Corporation Investor news 25 February 2022 at 10:00 a.m.Discussion event for shareholders on YIT’s events and financial statements in 2021 A discussion event related to YIT's 2021 events and financial statements will be held on Monday 28 February 2022 at 3.00 p.m. Finnish time (EET, at 1.00 p.m. GMT). In the event, the shareholders can ask questions from the Chairman of the Board and the President and CEO before the registration and advance voting of the Annual General Meeting. Shareholder are requested to take into consideration that the questions asked at the informal discussion

DanCann Pharma A/S publishes Q4-2021 report

COPENHAGEN, Denmark, 25 February 2022 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today releases its results for the period 1 October – 31 December 2021 (the “period”). The Q4-2021 report is available as an attached document to this press release and at www.dancann.com.Group key figures Q4 2021 KDKK 01/10/21 01/10/20 31/12/20 01/01/21 31/12/21 01/01/20 31/12/20 31/12/21Net sales 874 0 874 0Operating -4,718 -2,721 -14,509 -5,871

There are no items matching the current filter
There are no more items matching the current filter
Back to top